Tag: pharmaceuticals
-

Start-Up Developing Regenerative Liver Disease Treatments
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions.
-

Allergan Licensing Crispr for Inherited Eye Disease
Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10.
-

Precision Medicine Technique Devised for Brain Tumors
A process for quickly determining genetic mutations behind brain tumors and delivering a treatment addressing those mutations is shown to extend the survival of lab mice induced with those tumors.
-

Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses.
-

Despite Crisis, U.S. Prescription Opioid Use Remains High
A review of insurance claims over a 10-year period shows prescription opioid use in the U.S. remains at a high level with few signs of declining, despite repeated and vocal public concerns about these drugs.
-

Engineered Bacteria Studied for Rare Inherited Skin Disorder
A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children.
-

A.I. System Developed to Design Entirely New Drugs
A bioinformatics team developed a system combining machine learning and neural networks with large-scale databases to design entirely new drug molecules that meet desired chemical properties and biological activity.
-

Trial Shows Antibiotic More Effective Against Crohn’s Disease
Early results from a clinical trial show an experimental antibiotic drug helps more people achieve remission of their Crohn’s disease for longer periods than a similar group given a placebo.
-

Technique Assessed for Comparing Effectiveness Between Drugs
An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials.
-

NIH Small Business Grant Funds Severe Hepatitis Treatment
A biotechnology company is developing treatments for a severe form of hepatitis, which up to now has only limited therapy options, with a synthetic form of RNA designed to shut down the infecting virus.